International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma - Test2 - elhamkhani - TriplyDB

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

http://www.wikidata.org/entity/Q28303718

about

Surgery for localised small cell lung cancer Screening for lung cancer Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung Lung cancer staging: clinical and radiologic perspectives Update in lung cancer and mesothelioma 2012 Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results Surgical pathology of early stage non-small cell lung carcinoma The importance of the regimen of screening in maximizing the benefit and minimizing the harms Clinical impacts of a micropapillary pattern in lung adenocarcinoma: a review Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancer Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Lung cancer screening: past, present and future The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management EGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidence Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon's perspective Staging lymph node metastases from lung cancer in the mediastinum From tissue to molecular phenotyping: pre-analytical requirements heidelberg experience The new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issues Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids Can microRNAs improve the management of lung cancer patients? A clinician's perspective Utility of small biopsies for diagnosis of lung nodules: doing more with less The pivotal role of pathology in the management of lung cancer New TNM classification: achievements and hurdles Role of molecular studies in the diagnosis of lung adenocarcinoma Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Incidental, subsolid pulmonary nodules at CT: etiology and management Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement.Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers.Molecular pathology of non-small cell lung cancer: a practical guide.Molecular pathology of lung cancer: key to personalized medicine.Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.Overview of Clinical Progress in Pulmonary Ground-glass Nodules International association for the study of lung cancer map, Wang lymph node map and rapid on-site evaluation in transbronchial needle aspiration Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC Clinical applications of liquid biopsies in gastrointestinal oncology

P2860

Q24186777-73CECEAF-A9AA-41B4-8963-2E27E520DA89 Q24201867-B07BB7B9-3D59-4334-9F82-DC33BF536701 Q24303485-B9601181-5E30-4D60-A1D6-E32A0D03747A Q24600394-81765160-2EEE-44EE-8554-9C71F657F8D0 Q24619675-F7C8D087-F51E-40F8-867D-DE66FFEBA4D2 Q24630546-AD12F712-811D-4513-A181-20CD5B73CA40 Q26739713-44F4B751-E2C6-44F5-B920-A2CC9F071522 Q26747801-2A539C02-CB62-488D-95B2-6810445F3217 Q26771950-A3B61695-8A4B-4B7D-AA33-DF21F53247F4 Q26781810-153A0E84-3250-4774-8B89-FC1FFEDA77CE Q26784085-5F8464A1-C5C1-48FA-B7DD-B73E0E606740 Q26785713-EB557B79-7CAC-41D6-B984-4056E231F050 Q26823264-98BEC767-8411-44FC-915B-6E03C7A7592B Q26828860-CECC9FE0-5421-4FC3-A605-53568310F559 Q26829339-1C5E7B28-00FF-42FE-A687-7D1D34045595 Q26851443-C8DEB5E7-F526-4F5E-9B7C-B36EAF0CB16E Q26853071-E123E9AC-EA6F-4E9C-9280-0B758B74F8B1 Q26858898-2AA3ED45-0EAE-43BE-93CE-346C4C31A397 Q26863443-8B59DD14-F34F-48CC-9F2B-0358EA060165 Q26864637-6D8D0B5A-EA01-4DEE-A620-865DB9D99F23 Q26864736-67B70B50-C655-4C4B-AC9E-9BAFF0986159 Q26996521-5826AF9B-7567-4E0F-9A6A-35302AD05966 Q26999304-50D32CF1-C5AD-4017-B164-C0BFE7848B1F Q27009328-57862C2C-0E34-4850-A929-426BF53A4441 Q27010437-D8D6C9E8-2D4D-4CE5-B604-4F26E18DE241 Q27022737-5BC1A83D-67C0-417B-A4C6-2F2495CAAAE5 Q27023212-EFF74C23-8C50-4B50-9F2F-D6E503BC5F0C Q27025828-ED87CB1D-E642-4596-8DBD-FFB561B0467B Q27028124-B7E813BC-4DC6-46B7-AD5D-AA27EF3BB9CE Q27311389-FD78A240-17DE-4094-96A8-C338177F9F14 Q27330820-75741783-2549-4B1F-AA06-D091ABAC46E5 Q27690919-157D45D8-97DB-493D-B8A5-5ADDE888B23D Q27691299-8AF741C1-F365-4B0E-BF1B-F3636334C79A Q27852993-2E68C607-0E94-454C-A02C-F7D096747F5D Q27853055-F7D1E20D-6DEE-42EB-A4C8-2F85B27B5EE5 Q27853282-62B8C3A5-A045-46BA-B71A-1A56C740F351 Q28067318-0B17BB7F-0AE8-4D7D-B7CE-6ED8DC1B401B Q28073476-B80CB10D-8903-454B-B31C-D8E714791650 Q28073562-23B81486-BD43-4F75-AA05-8A2912F0D8A6 Q28073730-D6B68C2E-F1F2-40D6-82BD-4DE933F5EFEC

P2860

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

http://www.wikidata.org/entity/Q28303718

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

International association for ...... ication of lung adenocarcinoma

@ast

International association for ...... ication of lung adenocarcinoma

@en

International association for ...... ication of lung adenocarcinoma

@nl

type

label

International association for ...... ication of lung adenocarcinoma

@ast

International association for ...... ication of lung adenocarcinoma

@en

International association for ...... ication of lung adenocarcinoma

@nl

prefLabel

International association for ...... ication of lung adenocarcinoma

@ast

International association for ...... ication of lung adenocarcinoma

@en

International association for ...... ication of lung adenocarcinoma

@nl

P1433

Q28303718-02F5ED50-0F85-4404-8F92-9C74FE26C81D

P1476

Q28303718-E635F269-9259-4E87-97E2-9148BD964068

P2093

Q28303718-00C29DC2-FAF1-427C-B474-444C5629384D

Q28303718-069F3649-9628-4714-95BF-66749596A2F8

Q28303718-098E631C-71A5-4406-83B0-192B85BCE296

Q28303718-17F62603-5578-46BB-8BBC-497DB678349C

Q28303718-1B75CB83-6562-4637-B5CA-F0CE35016C57

Q28303718-1C80845F-4FE2-490E-A38B-7FCA3E004260

Q28303718-2405C6AA-B37E-499B-81E9-AFA1B7990903

Q28303718-31652569-8ACA-4633-B0BE-3F59E5154A50

Q28303718-326A9C9F-6BF2-4359-B00B-68FB5CABF2FD

Q28303718-3E0D7670-B285-4513-B084-D90F00AB2140

P2860

Q28303718-0061C540-6BE6-4323-84F8-EF7938913879

Q28303718-023789B5-54B8-41C3-945B-0DBAD165C9B7

Q28303718-028365C8-9869-4CF2-95BA-E2C8C70C9A7B

Q28303718-03154C5A-FAF9-4B62-B74B-07C53873184B

Q28303718-043505BB-E08B-4DDF-8AA0-42BB9B35BCDC

Q28303718-05728E57-7692-4E1B-820C-A06AE7F09790

Q28303718-07029C37-DBF9-4797-80E7-B3C9E8827093

Q28303718-071388DA-EAE1-493B-8E1C-8F48CB37FA58

Q28303718-0721DED3-9251-4C05-A26A-8AE833772AD1

Q28303718-073BD7A1-6E36-491C-9CF4-D825EB8B71CA

P304

Q28303718-C5469B6A-5A61-4EDA-8410-C988EFD901FE

P31

Q28303718-B53E23AE-00EB-4DB8-BC9C-9EAC5435143D

P3181

Q28303718-5F4F2D10-222F-443A-9B17-739F63798045

P356

Q28303718-8E96D523-F93D-4330-B4FC-8438AF3B22C1

P407

Q28303718-D0074EAA-4BF9-490D-93C2-8BD08A8EFEE1

P433

Q28303718-4B4F62CA-7507-4BAF-A769-DBA0E9DE0EEE

P478

Q28303718-E5A64D99-BA48-41A1-B1F3-F02F45F96A95

P50

Q28303718-05DF1E47-8B15-4B38-B397-FF07724E53EF

Q28303718-38E8A48F-865F-417F-BA3F-16CCF960DAFD

Q28303718-3D41E04B-79F4-462D-8014-5214EB29454A

Q28303718-4910750B-1C6B-4858-BD22-A995E84038DB

Q28303718-581CDBCD-05AF-4F60-ABF2-2AF876F2A163

Q28303718-687025DC-3EF1-46A7-B68F-B4A22BC68220

Q28303718-77864864-C441-4901-892C-2FDBFE1080B0

Q28303718-821D480C-21BC-4352-B3FE-FA1F6F02E39F

Q28303718-8FA7606A-E408-4A93-80E5-8D62A6D97BDD

Q28303718-9E87BC96-FFFA-4034-BD30-E01FEA851AA6

P577

Q28303718-129CBB6C-DAE1-4F30-8967-2982E0914385

P698

Q28303718-9CED5233-358C-4661-AB29-7E262613B192

P921

Q28303718-06CEDDDD-2D5E-4BAD-A64A-F98003DB17C6

P932

Q28303718-3995078A-BA43-4F7C-96F1-86D5398181CB

P3181

P356

JTO.0B013E318206A221

P1433

Journal of Thoracic Oncology

P1476

International association for ...... ication of lung adenocarcinoma

@en

P2093

Adi Gazdar

http://www.w3.org/2001/XMLSchema#string

Andrew G Nicholson

http://www.w3.org/2001/XMLSchema#string

Bruce Johnson

http://www.w3.org/2001/XMLSchema#string

Christian Brambilla

http://www.w3.org/2001/XMLSchema#string

David G Beer

http://www.w3.org/2001/XMLSchema#string

David Johnson

http://www.w3.org/2001/XMLSchema#string

David Yankelewitz

http://www.w3.org/2001/XMLSchema#string

Douglas Flieder

http://www.w3.org/2001/XMLSchema#string

Douglas Henderson

http://www.w3.org/2001/XMLSchema#string

Fred R Hirsch

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society 1

Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?

Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

What is "quality of evidence" and why is it important to clinicians?

Somatic mutations affect key pathways in lung adenocarcinoma

Characterizing the cancer genome in lung adenocarcinoma.

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features

P304

244-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

78848

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/JTO.0B013E318206A221

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Tetsuya Mitsudomi

Erik Thunnissen

Denise R. Aberle

Valerie W Rusch

Takashi Takahashi

Charles A Powell

Elisabeth Brambilla

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21252716

http://www.w3.org/2001/XMLSchema#string

P921

P932

4513953

http://www.w3.org/2001/XMLSchema#string